These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5172361)

  • 41. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 42. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
    Languillon J; Yawalkar SJ; McDougall AC
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
    [No Abstract]   [Full Text] [Related]  

  • 44. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082
    [No Abstract]   [Full Text] [Related]  

  • 46. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
    Vischer WA
    Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
    [No Abstract]   [Full Text] [Related]  

  • 47. Preliminary trial of intervention levamisole therapy in persistently bacteriologically positive lepromatous leprosy.
    Ramu G; Sengupta U
    Lepr India; 1983 Jan; 55(1):64-7. PubMed ID: 6876762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Schweninger-Buzzi anetoderma in women with or without lepromatous leprosy].
    Bechelli LM; Valeri V; Pimenta WP; Tanaka AM
    Dermatologica; 1967; 135(5):329-36. PubMed ID: 6062864
    [No Abstract]   [Full Text] [Related]  

  • 49. A study of dermatological conditions in leprosy in-patients.
    Patki AH; Jadhav VH; Mehta JM
    Indian J Lepr; 1989 Jan; 61(1):92-5. PubMed ID: 2522976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Disorders of the upper respiratory tract in lepromatous leprosy and their treatment].
    Usmanov RK
    Vestn Otorinolaringol; 1974; (3):88-92. PubMed ID: 4467412
    [No Abstract]   [Full Text] [Related]  

  • 51. Helicobacter pylori and associated histopathological changes in gastric biopsies of patients with leprosy.
    Misra V; Misra SP; Hatwal D; Dwivedi M; Singh KG; Bajaj AK
    Indian J Pathol Microbiol; 2001 Jul; 44(3):271-5. PubMed ID: 12024911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical evaluation of Lamprene (Geigy). A preliminary report.
    Karuru ER
    Lepr Rev; 1970 Apr; 41(2):83-8. PubMed ID: 5453083
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of lepromatous leprosy by ethionamide].
    Rollier R; Rollier M
    Maroc Med; 1972 Mar; 52(555):148-66. PubMed ID: 4261347
    [No Abstract]   [Full Text] [Related]  

  • 54. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 55. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 56. Clofazimine in leprosy.
    Schulz EJ
    Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339
    [No Abstract]   [Full Text] [Related]  

  • 57. A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
    Am J Trop Med Hyg; 1978 Sep; 27(5):1005-14. PubMed ID: 362950
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 60. [The Malta project (a program for the eradication of leprosy)].
    Freerksen E; Rosenfeld M; Despasquale G; Bonnici E
    Acta Leprol; 1988; 6(5):7-46. PubMed ID: 3078224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.